Attenuation of crgogenic induced brain oedema by arginine vasopressin release inhibitor RU51599

Acta Neurochirurgica

Volumn 139, Issue 12, 1997, Pages 1173-1180

  Ikeda, Y ^a   Teramoto, A ^a   Nakagawa, Y ^a   Ishibashi, Y ^a   Yoshii, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Arginine vasopressin; Brain oedema; Cryogenic injury; Kappa opioid

Indexed keywords

KAPPA OPIATE RECEPTOR AGONIST; N,N DIMETHYLFORMAMIDE; NALOXONE; NIRAVOLINE; OPIATE ANTAGONIST; POTASSIUM; SODIUM; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; WATER; ARGIPRESSIN; BENZENEACETAMIDE DERIVATIVE; DIAGNOSTIC AGENT; DIURETIC AGENT; EVANS BLUE; KAPPA OPIATE RECEPTOR; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN INFARCTION; BRAIN WATER; COLD INJURY; DRUG ANTAGONISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; ANIMAL; BRAIN INJURY; BRAIN LEVEL; COLD; DRUG POTENTIATION; PATHOPHYSIOLOGY; SECRETION; WISTAR RAT;

ANIMALS; ARGININE VASOPRESSIN; BENZENEACETAMIDES; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; BRAIN EDEMA; BRAIN INJURIES; COLD; DIURETICS; EVANS BLUE; MALE; NALOXONE; POTASSIUM; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; SODIUM; SPECTROPHOTOMETRY, ATOMIC;

EID: 0031298181     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01410979     Document Type: Article

References (25)

1. Baskin DS, Widmayer MA, Browning JL, Heizer ML, Schmit WK (1994) Evaluation of delayed treatment of focal cerebral ischemia with three selective κ-opioid agonists in cats. Stroke 25: 2047-2054
2. Chan PH, Young GY, Chen SF, Carlson E, Epstein CJ (1991) Cold-induced brain oedema and infarction are reduced in transgenic mice overexpressing Cu Zn-superoxide dismutase. Ann Neurol 29: 482-486
3. Dickinson LD, Betz AL (1992) Attenuated development of ischemic brain oedema in vasopressin-deficient rats. J Cereb Blood Flow Metab 12: 681-690
4. Dóczi T, László FA, Szerclahelyi P, Joó F (1984) Involvement of vasopressin in brain oedema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage. Neurosurgery 14: 436-441
5. Dóczi TP, Joo F, Balás I (1995) Atrial natriuretic peptide (ANP) attenuate brain oedema accompanying experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 132: 87-91
6. Faden AI (1986) Neuropeptides and central nervous system injury. Clinical implications. Arch Neural 43: 501-504
7. Faraci FM, Mayhan WG, Farrell WJ, Heistad DD (1988) Humoral regulation of blood flow to choroid plexus role of arginine vasopressin. Cir Res 63: 373-379
8. Furui T (1993) Potential protection by a specific kappa-opiate agonist U-50488H agonist membrane failure in acute ischemic brain. Neurol Med Clir (Tokyo) 33: 133-138
9. Guéniau C, Bertelau L, Oberlander C (1995) Protection from ischemic forcal cerebral oedema in mice by two kappa opioid receptor agonists, niravoline and U50488. J Cereb Blood Flow Metab 15 [Suppl 1]: S383
10. Hall ED, Walf DL, Althaus JS, Von Voightlander PF (1987) Beneficial effects of the κ-opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Brain Res 435: 174-180
11. Ikeda Y, Wang M, Nakazawa S (1994) Simple quantitative evaluation of blood brain barrier disruption in cold-induced brain oedema. Acta Neurochir [Suppl] 60 (Wien): 119-120
12. Isotani E, Suzuki R, Tomita K, Hokari M, Monma S, Maruno F, Hirakawa K (1994) Alternation in plasma concentration of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage. Stroke 25: 2198-2203
13. Kusumoto K, Marckay KB, McCulloch J (1992) The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischemia. Brain Res 576: 147-151
14. László FA, Varga C, Dóczi T (1995) Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin. Acta Neurochir (Wien) 133: 122-133
15. Mcintosh TK (1992) Pharmacologie strategies in the treatment of experimental brain injury. J Neurotrauma 9 [Suppl 1]: S201-S209
16. Mcintosh TK, Fernyak S, Yamakami I, Faden AI (1994) Central and systemic κ-opioid agonists exacerbate neurobehavioral response to brain injury in rats. Am J Physiol 267: R665-R672
17. Hamon G, Fortin M, Le Martret O, Jouquey S, Vincent JC, Bichet DG (1994) Pharmacological profile of niravoline, a new aquaretic conpound. J Am Soc Nephrol 5: 272
18. Nagao S, Kagawa M, Bemana I, Kuniyoshi T, Ogawa T, Honma Y, Kuyama H (1994) Treatment of vasogenic brain oedema with arginine vasopressin receptor antagonist - an experimental study. Acta Neurochir [Suppl] 60 (Wien): 502-504
19. Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, Tomita A (1988) Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Neuroendocrinology 48: 658-662
20. Raichle ME, Grubb RL (1978) Regulation of brain water permiability by centrally-released vasopressin. Brain Res 143: 191-194
21. Reeder RF, Nattie EE, North WG (1986) Effect of vasopressin on cold-induced brain oedema. J Neurosurg 64: 941-950
22. 1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain oedema in rats. Stroke 23: 1767-1774
23. Silvia RC, Slizgi GR, Ludens JH, Tang AH (1987) Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist. Brain Res 403: 52-57
24. Sorensen PS, Gjerris A, Hammer M (1985) Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. J Neurol Neurosurg Psychiatry 48: 50-57
25. Tang AH (1985) Protection from cerebral ischemia by U-50488E, a specific kappa opioid analgesic agent. Life Sci 37: 1475-1482